Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/61890
Full metadata record
DC FieldValueLanguage
dc.contributor.authorK. Subsaien_US
dc.contributor.authorS. Kanoksrien_US
dc.contributor.authorC. Siwapornen_US
dc.contributor.authorL. Helenen_US
dc.contributor.authorO. Kanokpornen_US
dc.contributor.authorP. Wantanaen_US
dc.date.accessioned2018-09-11T09:00:48Z-
dc.date.available2018-09-11T09:00:48Z-
dc.date.issued2006-03-01en_US
dc.identifier.issn14681331en_US
dc.identifier.issn13515101en_US
dc.identifier.other2-s2.0-33645305975en_US
dc.identifier.other10.1111/j.1468-1331.2006.01178.xen_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33645305975&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/61890-
dc.description.abstractThe positive role of highly active anti-retroviral therapy (HAART) in reducing opportunistic infections in acquired immunodeficiency syndrome (AIDS) patients is well known. However, case reports from around the world have demonstrated that some patients seem to suffer a paradoxical deterioration of health as their immune function improves with treatment. This phenomenon has been called immune restoration inflammatory syndrome (IRIS). In northern Thailand, GPO-vir (Stavudine-D4T + Lamivudine-3TC + Nevirapine-NVP) has been promoted for the treatment of AIDS patients since April 2002, in accordance with the Government Pharmaceutical Organization's guidelines. However, the incidence rates of IRIS affecting nervous system (NIRIS) and non-NIRIS in comparison with the previous incidence of AIDS-defining disease have not been reported. We conducted a retrospective study to review the incidence of NIRIS and non-NIRIS in AIDS patients treated with GPO-vir in Chiang Mai University Hospital, Thailand, between May 2002 and April 2004. We compare these incidence rates with the incidence rates of neurological complications in the pre-HAART era. Altogether 506 AIDS patients were treated with GPO-vir during the specified period. The overall incidence of NIRIS, including progressive multifocal leukoencephalopathy (PML), cerebral toxoplasmosis and cytomegalovirus (CMV) retinitis, was lower than the previous incidence of AIDS-defining disease in the pre-HAART era. However, the incidence of ischemic stroke, hemorrhagic stroke and primary central nervous system (CNS) lymphoma had increased. © 2006 EFNS.en_US
dc.subjectMedicineen_US
dc.subjectNeuroscienceen_US
dc.titleNeurological complications in AIDS patients receiving HAART: A 2-year retrospective studyen_US
dc.typeJournalen_US
article.title.sourcetitleEuropean Journal of Neurologyen_US
article.volume13en_US
article.stream.affiliationsChiang Mai Universityen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.